Jason Schafer, PharmD

Contact Dr. Schafer

130 South 9th Street
Suite 1540
Philadelphia, PA 19107

(215) 503-7522
(215) 503-9052 fax

Education
PharmD, Duquesne University, Pittsburgh, Pa

Residency
PGY-1: The Mercy Hospital of Pittsburgh, Pittsburgh, Pa.

PGY-2: The Ohio State University Medical Center, Columbus, Oh.

University Appointment
Assistant Professor of Pharmacy Practice, 2009

Research/Clinical Interests
Infectious diseases pharmacotherapy

Publications

Most recent Peer-reviewed Publications

1. Rilpivirine, a novel non-nucleoside reverse transcriptase inhibitor for the management of HIV-1 infection: A systematic review
2. A root cause analysis project in a medication safety course
3. A root cause analysis project in a medication safety course.
4. Risk factors associated with the conversion of meticillin-resistant Staphylococcus aureus colonisation to healthcare-associated infection
5. The Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 Infection
6. Extended-spectrum β-lactamase-producing bacterial infections in adult solid organ transplant recipients
7. Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus
8. Integrase inhibitors: A novel class of antiretroviral agents
9. Clinical decision support. How CDS tools impact patient care outcomes.
10. Doripenem: A new addition to the carbapanem class of antimicrobials
11. Establishing the role of tigecycline in an era of antimicrobial resistance
12. Implementing and improving the efficiency of a methicillin-resistant Staphylococcus aureus active surveillance program using information technology
13. Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq
14. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii